Nonmuscle myosin II regulates the morphogenesis of metanephric mesenchyme-derived immature nephrons

Journal of the American Society of Nephrology

Volumn 26, Issue 5, 2015, Pages 1081-1091

  Recuenco, Mariam C ^a,d   Ohmori, Tomoko ^a   Tanigawa, Shunsuke ^a   Taguchi, Atsuhiro ^a   Fujimura, Sayoko ^a   Conti, Mary Anne ^b   Wei, Qize ^b,e   Kiyonari, Hiroshi ^c   Abe, Takaya ^c   Adelstein, Robert S ^b   Nishinakamura, Ryuichi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c RIKEN Center for Biosystems Dynamics Research   (Japan)

^d UNIVERSITY OF THE PHILIPPINES LOS BAÑOS   (Philippines)

^e FORDHAM UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN II; NOTCH RECEPTOR; WNT PROTEIN; ISOPROTEIN; MYH9 PROTEIN, MOUSE; MYOSIN HEAVY CHAIN; MYOSIN IIA; MYOSIN IIB; NONMUSCLE MYOSIN TYPE IIB HEAVY CHAIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; EMBRYO; FOCAL GLOMERULOSCLEROSIS; GENE; GENE MUTATION; KIDNEY DEVELOPMENT; KIDNEY MALFORMATION; KIDNEY PROXIMAL TUBULE; KIF26B GENE; MESENCHYME; MORPHOGENESIS; MOUSE; MYH10 GENE; MYH9 GENE; NEPHRON; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; URETER; ANIMAL; C57BL MOUSE; EMBRYOLOGY; MESODERM; METABOLISM; NEWBORN; PHYSIOLOGY;

ANIMALS; ANIMALS, NEWBORN; MESODERM; MICE, INBRED C57BL; MORPHOGENESIS; MYOSIN HEAVY CHAINS; NEPHRONS; NONMUSCLE MYOSIN TYPE IIA; NONMUSCLE MYOSIN TYPE IIB; PROTEIN ISOFORMS;

EID: 84929330531     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014030281     Document Type: Article

References (33)

1. Kobayashi A, Valerius MT, Mugford JW, Carroll TJ, Self M, Oliver G, McMahon AP: Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 3: 169-181, 2008
2. Carroll TJ, Park J-S, Hayashi S, Majumdar A, McMahon AP: Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev Cell 9: 283-292, 2005
3. Self M, Lagutin OV, Bowling B, Hendrix J, Cai Y, Dressler GR, Oliver G: Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney. EMBO J 25: 5214-5228, 2006
4. Cheng HT, Kim M, Valerius MT, Surendran K, Schuster-Gossler K, Gossler A, McMahon AP, Kopan R: Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development 134: 801-811, 2007
5. Fujimura S, Jiang Q, Kobayashi C, Nishinakamura R: Notch2 activation in the embryonic kidney depletes nephron progenitors. J Am Soc Nephrol 21: 803-810, 2010
6. Conti MA, Adelstein RS: Nonmuscle myosin II moves in new directions. J Cell Sci 121: 11-18, 2008
7. Smutny M, Cox HL, Leerberg JM, Kovacs EM, Conti MA, Ferguson C, Hamilton NA, Parton RG, Adelstein RS, Yap AS: Myosin II isoforms identify distinct functional modules that support integrity of the epithelial zonula adherens. Nat Cell Biol 12: 696-702, 2010
8. Conti MA, Even-Ram S, Liu C, Yamada KM, Adelstein RS: Defects in cell adhesion and the visceral endoderm following ablation of nonmuscle myosin heavy chain II-A in mice. J Biol Chem 279: 41263-41266, 2004
9. Tullio AN, Accili D, Ferrans VJ, Yu ZX, Takeda K, Grinberg A, Westphal H, Preston YA, Adelstein RS: Nonmuscle myosin II-B is required for normal development of the mouse heart. Proc Natl Acad Sci U S A 94: 12407-12412, 1997
10. Ma X, Jana SS, Conti MA, Kawamoto S, Claycomb WC, Adelstein RS: Ablation of nonmuscle myosin II-B and II-C reveals a role for nonmuscle myosin II in cardiac myocyte karyokinesis. Mol Biol Cell 21: 3952-3962, 2010
11. Kelley MJ, Jawien W, Ortel TL, Korczak JF: Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat Genet 26: 106-108, 2000
12. Seri M, Cusano R, Gangarossa S, Caridi G, Bordo D, Lo Nigro C, Ghiggeri GM, Ravazzolo R, Savino M, Del Vecchio M, d'Apolito M, Iolascon A, Zelante LL, Savoia A, Balduini CL, Noris P, Magrini U, Belletti S, Heath KE, Babcock M, Glucksman MJ, Aliprandis E, Bizzaro N, Desnick RJ, Martignetti JA; The May-Heggllin/Fechtner Syndrome Consortium: Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. Nat Genet 26: 103-105, 2000
13. Sekine T, Konno M, Sasaki S, Moritani S, Miura T, Wong WS, Nishio H, Nishiguchi T, Ohuchi MY, Tsuchiya S, Matsuyama T, Kanegane H, Ida K, Miura K, Harita Y, Hattori M, Horita S, Igarashi T, Saito H, Kunishima S: Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease. Kidney Int 78: 207-214, 2010
14. Kao WHL, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Tandon A, Powe NR, Fink NE, Sadler JH, Weir MR, Abboud HE, Adler SG, Divers J, Iyengar SK, Freedman BI, Kimmel PL, Knowler WC, Kohn OF, Kramp K, Leehey DJ, Nicholas SB, Pahl MV, Schelling JR, Sedor JR, Thornley-Brown D, Winkler CA, Smith MW, Parekh RS: Family Investigation of Nephropathy and Diabetes Research Group: MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40: 1185-1192, 2008
15. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Kimmel PL, Korbet SM, Michel DM, Mokrzycki MH, Schelling JR, Simon E, Trachtman H, Vlahov D, Winkler CA: MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40: 1175-1184, 2008
16. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR: Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329: 841-845, 2010
17. Freedman BI, Kopp JB, Langefeld CD, Genovese G, Friedman DJ, Nelson GW, Winkler CA, Bowden DW, Pollak MR: The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol 21: 1422-1426, 2010
18. Uchiyama Y, Sakaguchi M, Terabayashi T, Inenaga T, Inoue S, Kobayashi C, Oshima N, Kiyonari H, Nakagata N, Sato Y, Sekiguchi K, Miki H, Araki E, Fujimura S, Tanaka SS, Nishinakamura R: Kif26b, a kinesin family gene, regulates adhesion of the embryonic kidney mesenchyme. Proc Natl Acad Sci U S A 107: 9240-9245, 2010
19. Yu J, Carroll TJ, McMahon AP: Sonic hedgehog regulates proliferation and differentiation of mesenchymal cells in the mouse metanephric kidney. Development 129: 5301-5312, 2002
20. Nishinakamura R, Matsumoto Y, Nakao K, Nakamura K, Sato A, Copeland NG, Gilbert DJ, Jenkins NA, Scully S, Lacey DL, Katsuki M, Asashima M, Yokota T: Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development. Development 128: 3105-3115, 2001
21. Yang Z, Zimmerman S, Brakeman PR, Beaudoin GM 3rd, Reichardt LF, Marciano DK: De novo lumen formation and elongation in the developing nephron: A central role for afadin in apical polarity. Development 140: 1774-1784, 2013
22. Matsumoto S, Fujii S, Sato A, Ibuka S, Kagawa Y, Ishii M, Kikuchi A: A combination of Wnt and growth factor signaling induces Arl4c expression to form epithelial tubular structures. EMBO J 33: 702-718, 2014
23. Linton JM, Martin GR, Reichardt LF: The ECM protein nephronectin promotes kidney development via integrin alpha8beta1-mediated stimulation of Gdnf expression. Development 134: 2501-2509, 2007
24. Bedzhov I, Zernicka-Goetz M: Self-organizing properties of mouse pluripotent cells initiate morphogenesis upon implantation. Cell 156: 1032-1044, 2014
25. Lienkamp SS, Liu K, Karner CM, Carroll TJ, Ronneberger O, Wallingford JB, Walz G: Vertebrate kidney tubules elongate using a planar cell polarity-dependent, rosette-based mechanism of convergent extension. Nat Genet 44: 1382-1387, 2012
26. Johnstone DB, Zhang J, George B, Léon C, Gachet C, Wong H, Parekh R, Holzman LB: Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy. Mol Cell Biol 31: 2162-2170, 2011
27. Johnstone DB, Ikizler O, Zhang J, Holzman LB: Background strain and the differential susceptibility of podocyte-specific deletion of Myh9 on murine models of experimental glomerulosclerosis and HIV nephropathy. PLoS ONE 8: e67839, 2013
28. Zhang Y, Conti MA, Malide D, Dong F, Wang A, Shmist YA, Liu C, Zerfas P, Daniels MP, Chan C-C, Kozin E, Kachar B, Kelley MJ, Kopp JB, Adelstein RS: Mouse models of MYH9-related disease: Mutations in nonmuscle myosin II-A. Blood 119: 238-250, 2012
29. Taguchi A, Kaku Y, Ohmori T, Sharmin S, Ogawa M, Sasaki H, Nishinakamura R: Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell 14: 53-67, 2014
30. Kanda S, Tanigawa S, Ohmori T, Taguchi A, Kudo K, Suzuki Y, Sato Y, Hino S, Sander M, Perantoni AO, Sugano S, Nakao M, Nishinakamura R: Sall1 maintains nephron progenitors and nascent nephrons by acting as both an activator and a repressor [published online ahead of print April 17, 2014]. J Am Soc Nephrol
31. Jacobelli J, Friedman RS, Conti MA, Lennon-Dumenil A-M, Piel M, Sorensen CM, Adelstein RS, Krummel MF: Confinement-optimized three-dimensional T cell amoeboid motility is modulated via myosin IIA-regulated adhesions. Nat Immunol 11: 953-961, 2010
32. Ma X, Takeda K, Singh A, Yu Z-X, Zerfas P, Blount A, Liu C, Towbin JA, Schneider MD, Adelstein RS, Wei Q: Conditional ablation of nonmuscle myosin II-B delineates heart defects in adult mice. Circ Res 105: 1102-1109, 2009
33. Sakaki-Yumoto M, Kobayashi C, Sato A, Fujimura S, Matsumoto Y, Takasato M, Kodama T, Aburatani H, Asashima M, Yoshida N, Nishinakamura R: The murine homolog of SALL4, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with Sall1 in anorectal, heart, brain and kidney development. Development 133: 3005-3013, 2006